| Literature DB >> 22688402 |
F del Prete1, T Nizegorodcew, P Regazzoni.
Abstract
BACKGROUND: Fixation of pertrochanteric fracture is undoubtedly an additional trauma after the fracture itself. In elderly patients, it might have an important impact on the whole organism. In the literature we find various techniques to perform this type of surgery. Up to now, there are no parameters validated for quantification of the invasiveness of a surgical procedure; it is therefore still not demonstrated that any method is less invasive than any other. In an effort to find a way to quantify the invasiveness of a surgical procedure, inflammatory markers were collected in patients undergoing fixation of trochanteric fracture with gliding hip screw [dynamic hip screw (DHS)] using either a conventional (DHS conv) or minimally invasive (DHS MIO) technique.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22688402 PMCID: PMC3427700 DOI: 10.1007/s10195-012-0199-6
Source DB: PubMed Journal: J Orthop Traumatol ISSN: 1590-9921
Preoperative characteristics of patients
| Conventional (36 subjects) | MIO (32 subjects) | Average difference (95 % CI) | ||
|---|---|---|---|---|
| Age (years) | 84.7 ± 7.20 | 82.78 ± 7.71 | 1.91 (−1.69 to 5.52) | 0.2938 |
| Type of fracture | 1.89 ± 0.67 | 2.00 ± 0.57 | −0.11 (−0.41 to 0.19) | 0.4650 |
| Time from hospitalization to surgery (h) | 57.58 ± 28.04 | 56.97 ± 52.76 | 0.61 (−19.53 to 20.76) | 0.9516 |
| Anticoagulant/antiplateleta | 0.47 ± 0.51 | 0.37 ± 0.49 | 0.09 (−0.14 to 0.34) | 0.4260 |
| Number of comorbidities | 2.33 ± 1.35 | 2.56 ± 1.24 | −0.23 (−0.86 to 0.40) | 0.4713 |
There are no significant differences between the two groups (Student t test)
aOne patient used oral anticoagulants (coumarin) and 12 used oral antiplatelet drugs in the MIO group. Two patients used oral anticoagulants and 17 used oral antiplatelet drugs in the DHS conv group
Perioperative data
| Conventional (36 subjects) | MIO (32 subjects) | Average difference (95 % CI) | ||
|---|---|---|---|---|
| Length of incision (cm) | 11.65 ± 2.64 | 7.05 ± 1.77 | 4.61 (3.50 to 5.71) |
|
| Duration of surgery (min) | 56.67 ± 22.42 | 54.84 ± 15.94 | 1.82 (−7.71 to 11.35) | 0.7038 |
| Type of fixation | 1.89 ± 0.67 | 2.00 ± 0.57 | −0.11 (−0.41 to 0.19) | 0.4650 |
| Units transfused | 2.22 ± 0.99 | 1.09 ± 1.20 | 1.13 (0.59 to 1.66) |
|
Bold values indicate significant differences found for length of incision and units transfused (Student t test)
Chi-square test for discrete quantitative variables
| Conventional (36 subjects) | MIO (32 subjects) | ||
|---|---|---|---|
| Sex | |||
| Men | 4 (30.8 %) | 9 (69.2 %) | 0.0771 |
| Females | 32 (58.2 %) | 23 (41.8 %) | |
| Type of fracture | 0.4442 | ||
| A1 | 10 (66.7 %) | 5 (33.3 %) | 0.5383b |
| A2 | 20 (47.6 %) | 22 (52.4 %) | 0.2087c |
| A3 | 6 (54.5 %) | 5 (45.5 %) | 0.6853d |
| Type of fixation | 0.3218 | ||
| Type 1 (2–3 holes) | 7 (38.9 %) | 11 (61.1 %) | 0.2866b |
| Type 2 (4 holes + ATSP/antirot. screw/cercl.) | 12 (63.2 %) | 7 (36.8 %) | 0.1454c |
| Type 3 (5 or more holes/+ATSP/antirot. screw/cercl.) | 17 (54.8 %) | 14 (45.2 %) | 0.5668d |
| Anticoagulant/antiplatelet | 17 (58.6 %) | 12 (41.4 %) | 0.4184 |
Some variables such as sex, type of diagnosis, type of fixation, and taking anticoagulant/antiplatelet drugs were grouped into discrete quantitative variables, for which we performed the chi-square test to assess significant differences between the two groups. There were no significant differences between groups for these variables
aChi-square with two degrees of freedom in a 3 × 2 contingency table. Chi-square breakdown to compare the classes of covariates:
bFirst class with third class
cFirst class with second class
dSecond class with third class
Levels of interleukins pre- and postoperatively
| Conventional (36 subjects) | MIO (32 subjects) | Average difference (95 % CI) | ||
|---|---|---|---|---|
| IL-6 preoperatively | 39.57 ± 47.77 | 25.21 ± 29.73 | 14.37 (−5.19 to 33.92) | 0.1472 |
| IL-6 postoperatively | 78.41 ± 67.04 | 39.02 ± 37.36 | 39.39 (12.65 to 66.13) | 0.0045 |
| IL-8 preoperatively | 244.69 ± 476.18 | 248.57 ± 518.68 | −3.88 (−337.20 to 329.48) | 0.9813 |
| IL-8 postoperatively | 32.88 ± 7.40 | 73.91 ± 105.47 | −41.04 (−87.70 to 5.63) | 0.0829 |
| IL-10 preoperatively | 4.51 ± 3.19 | 2.89 ± 1.55 | 1.62 (0.38−2.86) | 0.0110 |
| IL-10 postoperatively | 11.27 ± 19.74 | 8.90 ± 24.89 | 2.37 (−8.45 to 13.19) | 0.6634 |
| TNF-α preoperatively | 30.56 ± 30.19 | 26.38 ± 19.19 | 4.18 (−8.39 to 16.76) | 0.5092 |
| TNF-α postoperatively | 39.52 ± 55.13 | 23.44 ± 17.31 | 16.08 (−4.54 to 36.70) | 0.1241 |
The table shows the levels of interleukins IL-6, IL-8, IL-10, and TNF-α before and after operation and the comparison between the two groups; values are expressed in pg/ml. IL-6 level shows no significant difference between the two groups in the preoperative phase, whereas it becomes significant in the postoperative period (Student t test)
Fig. 1Pre and post-operatively distribution (difference) of IL6, IL10 and TNF-α, for type of surgery
Level of significance for postoperative IL-6 by type of fixation (chi-square p value likelihood ratio)
| Type of fixation | 0.2563a |
| Type 1 (2–3 holes) | 0.0741b |
| Type 2 (4 holes + ATSP/antirot. screw/cercl.) | 0.0475c |
| Type 3 (5 or more holes/+ATSP/antirot. screw/cercl.) | 0.1912d |
aTotal
bType 1 versus type 3
cType 1 versus type 2
dType 1 versus type 2 + type 3